Back
Bicara Therapeutics Vs. AppLovin Industry Stock Comparison
Buy
59
BCAX
Bicara Therapeutics
Last Price:
$12.44
Seasonality Move:
--
Buy
64
APP
AppLovin
Last Price:
$258.88
Seasonality Move:
17.21%
Buy
59
Bicara Therapeutics (BCAX)
is a Buy
Is Bicara Therapeutics a Buy, Sell or Hold?
-
The current Bicara Therapeutics [BCAX] share price is $13.26. The Score for BCAX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
BCAX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $13.26Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing slight buying pressure.
APP Stock Price Chart
BCAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 49.46 | Sell |
Chaikin Money Flow: | 231472 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.38 - 14.42) | Sell |
Bollinger Bands (100): | (12.19 - 19.63) | Sell |
APP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -16.36 | Sell |
Relative Strength Index (14 RSI): | 46.05 | Sell |
Chaikin Money Flow: | 2225251 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (271.11 - 326.87) | Sell |
Bollinger Bands (100): | (275.49 - 387.97) | Sell |
BCAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.21 | Buy |
20-day SMA: | 13.54 | Sell |
50-day SMA: | 12.98 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 13.14 | Buy |
20-day EMA: | 13.24 | Buy |
50-day EMA: | 13.68 | Sell |
200-day EMA: | 11.37 | Buy |
APP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 298.22 | Sell |
20-day SMA: | 291.65 | Sell |
50-day SMA: | 345.45 | Sell |
200-day SMA: | 217.58 | Buy |
8-day EMA: | 289.67 | Buy |
20-day EMA: | 303.91 | Sell |
50-day EMA: | 322.17 | Sell |
200-day EMA: | 244.33 | Buy |
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and a decrease next year of $0.51 per share.
AppLovin Earnings Growth & APP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.89 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.15 per share, and an increase next year of $1.87 per share.
Bicara Therapeutics Technical Analysis
Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
AppLovin Technical Analysis
Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |